Lifeward LTD DEF 14A proxy statements

Lifeward Ltd. will hold an Extraordinary General Meeting on January 6, 2026, to vote on proposals including a reverse share split to maintain its Nasdaq listing and an increase in authorized share capital.

Lifeward Ltd. has issued its definitive proxy statement for the 2025 Annual Meeting, proposing the ratification of its new President and co-Chief Executive Officer's compensation, an increase in authorized share capital to facilitate future financing, and the approval of a new incentive compensation plan, against a backdrop of significant declines in total shareholder return and continued net losses.

Lifeward Ltd. announces the postponement of its Extraordinary General Meeting of Shareholders due to an anticipated lack of quorum, rescheduling it to January 13, 2025.

Lifeward Ltd. has scheduled an Extraordinary General Meeting for December 30, 2024, to vote on proposals including eliminating the par value of ordinary shares and approving a new incentive compensation plan.

ReWalk Robotics successfully defended against a shareholder's legal action seeking to add their director nominees to the agenda of the upcoming Annual Meeting.

ReWalk Robotics is contesting a shareholder's attempt to add their director nominees to the agenda of the upcoming Annual Meeting, leading to a legal dispute.

ReWalk Robotics (Lifeward) is holding its 2024 Annual Meeting of Shareholders to vote on key proposals including a name change, director elections, executive compensation, and reappointment of its accounting firm.